Every lot is tried & tested in a relevant biological assay.
Our Bioassay
- Hopkins, W.F. (1998) J. Pharmacol. Exp. Therap. 285, 1051.
- Harvey, A.L. (2001) Toxicon 39, 15.
- Alomone Labs Dendrotoxin-I inhibits KV1.1 and KV1.2 channel currents heterologously expressed in Xenopus oocytes.KV1.1 (left, in 2 mM K+) and KV1.2 (right, in 5 mM K+) channel currents, elicited by 200 ms depolarization from holding potential of -100 mV to +20 mV, before and during application of 100 nM Dendrotoxin-I (#D-390). 92% (n = 4) of the KV1.1 and 84% (n = 4) of the KV1.2 channels currents were inhibited by 100 nM Dendrotoxin-I, respectively.
- Schweitz, H. et al. (1990) Toxicon 28, 847.
- Hopkins, W.F. (1998) J. Pharmacol. Exp. Therap. 285, 1051.
- Harvey, A.L. (2001) Toxicon 39, 15.
Dendrotoxin-I is isolated from Dendroaspis p.polylepis snake venom by modification of the procedure of Schweitz1 and purified to homogeneity.
Dendrotoxin-I blocks KV1.2 and KV1.1 channels (IC50=0.13 and 3.1 nM in oocytes respectively, with higher values for mammalian cells)3 as well as heteromultimeric channels containing these, with other KV1 isoforms2 (for review see 3).
Alomone Labs Dendrotoxin-I shifts the resting potential of avian high characteristic frequency region of nucleus magnocellularis neurons.Voltage responses of a high characteristic frequency (CF) neuron in control (left panel) and in presence of Dendrotoxin-I (#D-390), (right panel). Application of Dendrotoxin-I shifts the resting potential from -75 to -64 mV and reduces the threshold current. Neurons show multiple action potentials in the presence of Dendrotoxin-I.Adapted from Fukui, I. and Ohmori, H. (2004) J. Neurosci. 24, 7514. with permission of the Society for Neuroscience.
Dendrotoxin-I (#D-390) is a highly pure, natural, and biologically active peptide toxin.
Applications
Citations
- Wright, T. et al. (2016) Sci. Rep. 6, 28584.
- Sforna, L. et al. (2015) J. Neurophysiol. 113, 2653.
- Hardman, R.M. and Forsythe, I.D. (2009) J. Physiol. 587, 2487.
- Johnston, J. et al. (2008) Eur. J. Neurosci. 27, 1391.
- Johnston, J. et al. (2008) J. Physiol. 586, 3493.
- Sinha, K. et al. (2006) J. Neurophysiol. 95, 1683.
- Eftekharpour, E. et al. (2005) Exp. Neurol. 193, 334.
- Shibukawa, Y. et al. (2005) Biophys. J. 88, 3924.
- Svirskis, G. et al. (2004) J. Neurophysiol. 91, 2465.
- Svirskis, G. et al. (2002) J. Neurosci. 22, 11019.
- Monsivais, P and Rubel, E.W. (2001) J. Neurosci. 21, 7823.
- Petersson, J. et al. (1997) Br. J. Pharmacol. 120, 1344.
Specifications
Scientific Background
Related Products
Antibodies
Pharmacological tools
Explorer kits & Research packs
Need Help With This Product?
Our reagent specialists are here to help you find the best product for your application. Please call or email us and we will be happy to help you find the right product for the job.
Call us at
+972 2587 2202 or Email Us